2021
DOI: 10.3389/fphar.2021.763181
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Neurorepair for Motor Functional Recovery Enhanced by Total Saponins From Trillium tschonoskii Maxim. Treatment in a Rat Model of Focal Ischemia

Abstract: Trillium tschonoskii Maxim. (TTM), is a perennial herb from Liliaceae, that has been widely used as a traditional Chinese medicine treating cephalgia and traumatic hemorrhage. The present work was designed to investigate whether the total saponins from Trillium tschonoskii Maxim. (TSTT) would promote brain remodeling and improve gait impairment in the chronic phase of ischemic stroke. A focal ischemic model of male Sprague-Dawley (SD) rats was established by permanent middle cerebral artery occlusion (MCAO). S… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 52 publications
0
3
0
Order By: Relevance
“…As was previously mentioned, phosphorylation of DRP2 by GSK-3β impairs its activity, leading to the inhibition of axonal/dendritic growth and neuronal activity, and inducing neuronal injury [35,36,[45][46][47]. This DRP2 phosphorylation regulation has been a target for therapeutic intervention, with treatments that regulate the Akt-GSK-3β-DRP2 signalling pathway in cerebral ischemia [43,48,49]. These treatments prevented the decrease of phospho-Akt and phospho-GSK-3β levels induced by ischemia, reducing the ischemiainduced increase of phospho-DRP2 by "active" dephospho-GSK-3β, and improving the integrity and protection of axons/dendrites against ischemic injury.…”
Section: Discussionmentioning
confidence: 97%
“…As was previously mentioned, phosphorylation of DRP2 by GSK-3β impairs its activity, leading to the inhibition of axonal/dendritic growth and neuronal activity, and inducing neuronal injury [35,36,[45][46][47]. This DRP2 phosphorylation regulation has been a target for therapeutic intervention, with treatments that regulate the Akt-GSK-3β-DRP2 signalling pathway in cerebral ischemia [43,48,49]. These treatments prevented the decrease of phospho-Akt and phospho-GSK-3β levels induced by ischemia, reducing the ischemiainduced increase of phospho-DRP2 by "active" dephospho-GSK-3β, and improving the integrity and protection of axons/dendrites against ischemic injury.…”
Section: Discussionmentioning
confidence: 97%
“…This is a novel research direction in the future. New research shows that by regulating axonal remodeling through the GSK-3/β-catenin/CRMP-2 pathway, short-term interventions with TTST may promote the recovery of brain function (Yang et al, 2021a). Another study examining the role of 30 days TTST gavage in the chronic phase of the ischemic stroke demonstrated that TTST improved gait impairment in MCAO rats by activating axonal remodeling and the PI3K/AKT/ GSK-3/CRMP-2 pathway (Yang et al, 2021b).…”
Section: Discussionmentioning
confidence: 99%
“…A series of gait statistics were automatically generated when the system identified and marked each footprint. The statistics included the following parameters: "Base of Support", "Print paw area", "Intensity of paw contact", "Max area of paw contact", "Support time", "Duty cycle"," Stride length", "Swing speed", and "Regularity Index" [90,[106][107][108][109].…”
Section: Catwalk™ Xtmentioning
confidence: 99%